NUVB Q2 2024 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$88,0006.1% margin

Operating Income

-$470M-32779.4% margin

Net Income

-$462M-32229.4% margin

EPS (Diluted)

$-1.89

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$595M

Total Liabilities

$338M

Stockholders' Equity

$257M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$88,000	$0	—
Operating Income	-$470M	-$26M	-1700.1%
Net Income	-$462M	-$21M	-2140.8%